HomeNDC LookupIngredients › Cysteamine Bitartrate
📦 NDC / package directory — not a drug information page

Cysteamine Bitartrate NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Cysteamine Bitartrate products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

18
Package NDCs
15
Products
15
Active listings
0
Discontinued
7
Labelers
8
Strengths
4
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
CYSTEAMINE BITARTRATE 75 mg/1 4
CYSTEAMINE BITARTRATE 1 kg/kg 3
CYSTEAMINE BITARTRATE 25 mg/1 2
CYSTEAMINE BITARTRATE 300 mg/1 2
CYSTEAMINE BITARTRATE 150 mg/1 1
CYSTEAMINE BITARTRATE 50 kg/50kg 1
CYSTEAMINE BITARTRATE 50 mg/1 1
CYSTEAMINE BITARTRATE 1 g/g 1
By dosage form
POWDER 5
CAPSULE, DELAYED RELEASE PELLETS 4
GRANULE, DELAYED RELEASE 4
CAPSULE 2
Top labelers
Horizon Therapeutics USA, Inc. 8
Mylan Pharmaceuticals Inc. 2
Anonima Materie Sintetiche and Aff... 1
Azico Biophore India Private Limit... 1
Cambrex Profarmaco Milano Srl 1
Farmabios S.p.A. 1
Maithri Laboratories Private Limit... 1

Browse records — 15 products

Drug / product Billing NDC NADAC / unit Status
Cystagon cysteamine bitartrate 150 mg/1 CAPSULE Mylan · NDC 00378-9045-05 · 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-9045-05) 00378-9045-05 On market View →
Cystagon cysteamine bitartrate 50 mg/1 CAPSULE Mylan · NDC 00378-9040-05 · 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-9040-05) 00378-9040-05 On market View →
Cysteamine bitartrate 50 kg/50kg POWDER Azico · NDC 69575-4054-01 · 50 kg in 1 DRUM (69575-4054-1) 69575-4054-01 On market View →
Cysteamine Bitartrate 1 kg/kg POWDER Cambrex · NDC 12828-0068-01 · 50 kg in 1 DRUM (12828-0068-1) 12828-0068-01 On market View →
Cysteamine Bitartrate 1 kg/kg POWDER Maithri · NDC 71666-0010-01 · 50 kg in 1 DRUM (71666-010-01) 71666-0010-01 On market View →
Cysteamine bitartrate 1 g/g POWDER Farmabios · NDC 46439-8762-01 · 20000 g in 1 DRUM (46439-8762-1) 46439-8762-01 On market View →
Cysteamine bitartrate 1 kg/kg POWDER Anonima · NDC 17373-1199-00 · 25 kg in 1 DRUM (17373-1199-0) 17373-1199-00 On market View →
PROCYSBI Cysteamine bitartrate 25 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0100-04 · 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-100-04) 75987-0100-04 On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0101-08 · 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-101-08) 75987-0101-08 On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0140-13 · 60 PACKET in 1 CARTON (75987-140-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0140-13 On market View →
PROCYSBI Cysteamine bitartrate 300 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0145-13 · 60 PACKET in 1 CARTON (75987-145-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0145-13 On market View →
PROCYSBI Cysteamine bitartrate 300 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0145-13 · 60 PACKET in 1 CARTON (75987-145-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0145-13 On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 GRANULE, DELAYED RELEASE Horizon · NDC 75987-0140-13 · 60 PACKET in 1 CARTON (75987-140-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET 75987-0140-13 On market View →
PROCYSBI Cysteamine bitartrate 25 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0100-04 · 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-100-04) 75987-0100-04 On market View →
PROCYSBI Cysteamine bitartrate 75 mg/1 CAPSULE, DELAYED RELEASE PELLETS Horizon · NDC 75987-0101-08 · 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-101-08) 75987-0101-08 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.